Life Sciences Group Of The Year: Fish & Richardson

Law360, New York (January 26, 2018, 3:42 PM EST) -- Fish & Richardson PC led Coherus BioScience in invalidating three Humira patents, won GlaxoSmithKline $235 million in a post-market infringement challenge and scored $14 million in attorneys' fees in the roller coaster aftermath of a $200 million infringement verdict, earning the firm a spot among Law360's 2017 Life Sciences Groups of the Year.

About a third of the intellectual property firm's 373 attorneys focus on life sciences, ranging in abilities from Hatch-Waxman litigation to Patent Trial and Appeal Board challenges to patent prosecution and building portfolios. That breadth of expertise helps the firm serve big-name clients like GSK and Gilead Sciences...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!